These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 18678846)
1. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Lin K; Lipsitz R; Miller T; Janakiraman S; Ann Intern Med; 2008 Aug; 149(3):192-9. PubMed ID: 18678846 [TBL] [Abstract][Full Text] [Related]
2. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force Ann Intern Med; 2008 Aug; 149(3):185-91. PubMed ID: 18678845 [TBL] [Abstract][Full Text] [Related]
3. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018 [TBL] [Abstract][Full Text] [Related]
4. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017 [TBL] [Abstract][Full Text] [Related]
5. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740 [TBL] [Abstract][Full Text] [Related]
6. Summaries for patients. Screening for prostate cancer with prostate-specific antigen testing: U.S. Preventive Services Task Force recommendations. Ann Intern Med; 2008 Aug; 149(3):I37. PubMed ID: 18678840 [No Abstract] [Full Text] [Related]
7. Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms. Gulati R; Gore JL; Etzioni R Ann Intern Med; 2013 Feb; 158(3):145-53. PubMed ID: 23381039 [TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Harris R; Lohr KN Ann Intern Med; 2002 Dec; 137(11):917-29. PubMed ID: 12458993 [TBL] [Abstract][Full Text] [Related]
9. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Moyer VA; Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674 [TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. Hayes JH; Barry MJ JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604 [TBL] [Abstract][Full Text] [Related]
11. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Wolff T; Tai E; Miller T Ann Intern Med; 2009 Feb; 150(3):194-8. PubMed ID: 19189909 [TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening. Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025 [TBL] [Abstract][Full Text] [Related]
13. PSA-based screening for prostate cancer. Too many adverse effects. Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259 [TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Lim LS; Sherin K; Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648 [TBL] [Abstract][Full Text] [Related]